These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 38304372)

  • 21. The efficacy of procalcitonin as a biomarker in the management of sepsis: slaying dragons or tilting at windmills?
    Sridharan P; Chamberlain RS
    Surg Infect (Larchmt); 2013 Dec; 14(6):489-511. PubMed ID: 24274059
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Procalcitonin-guided diagnosis and antibiotic stewardship revisited.
    Sager R; Kutz A; Mueller B; Schuetz P
    BMC Med; 2017 Jan; 15(1):15. PubMed ID: 28114931
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis to determine cost-effectiveness of procalcitonin-guided antibiotic use in adult patients with suspected bacterial infection and sepsis.
    Collins CD; Brockhaus K; Sim T; Suneja A; Malani AN
    Am J Health Syst Pharm; 2019 Aug; 76(16):1219-1225. PubMed ID: 31369118
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Implementation of Procalcitonin in Antibiotic Stewardship: Derivation of a Consensus Algorithm for Procalcitonin Use in Clinical Practice.
    Park DW; Choi JY; Kim CJ; Kim JH; Kim HB; Lee DG
    Infect Chemother; 2022 Dec; 54(4):621-636. PubMed ID: 36596678
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Procalcitonin-guided antibiotic therapy may shorten length of treatment and may improve survival-a systematic review and meta-analysis.
    Papp M; Kiss N; Baka M; Trásy D; Zubek L; Fehérvári P; Harnos A; Turan C; Hegyi P; Molnár Z
    Crit Care; 2023 Oct; 27(1):394. PubMed ID: 37833778
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of procalcitonin-guided antibiotic treatment on clinical outcomes in intensive care unit patients with infection and sepsis patients: a patient-level meta-analysis of randomized trials.
    Wirz Y; Meier MA; Bouadma L; Luyt CE; Wolff M; Chastre J; Tubach F; Schroeder S; Nobre V; Annane D; Reinhart K; Damas P; Nijsten M; Shajiei A; deLange DW; Deliberato RO; Oliveira CF; Shehabi Y; van Oers JAH; Beishuizen A; Girbes ARJ; de Jong E; Mueller B; Schuetz P
    Crit Care; 2018 Aug; 22(1):191. PubMed ID: 30111341
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The budget impact of procalcitonin-guided antibiotic stewardship compared to standard of care for patients with suspected sepsis admitted to the intensive care unit in Belgium.
    Garnfeldt VM; Vincent JL; Gruson D; Garay OU; Vansieleghem S; Iniguez L; Lefevre A
    PLoS One; 2023; 18(10):e0293544. PubMed ID: 37903106
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of biomarkers to individualize antimicrobial therapy duration: a narrative review.
    Scott J; Deresinski S
    Clin Microbiol Infect; 2023 Feb; 29(2):160-164. PubMed ID: 36096429
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Procalcitonin-guided antibiotic treatment in critically ill patients.
    Hohn A; Heising B; Schütte JK; Schroeder O; Schröder S
    Langenbecks Arch Surg; 2017 Feb; 402(1):1-13. PubMed ID: 27283067
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antibiotic stewardship: Early discontinuation of antibiotics based on procalcitonin level in COVID-19 pneumonia.
    Roy A; Powers HR; Craver EC; Nazareno MD; Yarrarapu SNS; Sanghavi DK
    J Clin Pharm Ther; 2022 Feb; 47(2):243-247. PubMed ID: 34766357
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of a Procalcitonin-guided Antibiotic Treatment Algorithm in the Pediatric Intensive Care Unit.
    Katz SE; Crook J; Gillon J; Stanford JE; Wang L; Colby JM; Banerjee R
    Pediatr Infect Dis J; 2021 Apr; 40(4):333-337. PubMed ID: 33181782
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Procalcitonin-guided algorithm to reduce length of antibiotic therapy in patients with severe sepsis and septic shock.
    Hohn A; Schroeder S; Gehrt A; Bernhardt K; Bein B; Wegscheider K; Hochreiter M
    BMC Infect Dis; 2013 Apr; 13():158. PubMed ID: 23547790
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Procalcitonin testing to guide antibiotic therapy for the treatment of sepsis in intensive care settings and for suspected bacterial infection in emergency department settings: a systematic review and cost-effectiveness analysis.
    Westwood M; Ramaekers B; Whiting P; Tomini F; Joore M; Armstrong N; Ryder S; Stirk L; Severens J; Kleijnen J
    Health Technol Assess; 2015 Nov; 19(96):v-xxv, 1-236. PubMed ID: 26569153
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Procalcitonin-guided antibiotic therapy in patients with fever in a general emergency department population: a multicentre non-inferiority randomized clinical trial (HiTEMP study).
    van der Does Y; Limper M; Jie KE; Schuit SCE; Jansen H; Pernot N; van Rosmalen J; Poley MJ; Ramakers C; Patka P; van Gorp ECM; Rood PPM
    Clin Microbiol Infect; 2018 Dec; 24(12):1282-1289. PubMed ID: 29870855
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Point-of-care multiplex molecular diagnosis coupled with procalcitonin-guided algorithm for antibiotic stewardship in lower respiratory tract infection: a randomized controlled trial.
    Velly L; Cancella de Abreu M; Boutolleau D; Cherubini I; Houas E; Aurousseau A; Hausfater P
    Clin Microbiol Infect; 2023 Nov; 29(11):1409-1416. PubMed ID: 37549731
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effectiveness of procalcitonin-guided antibiotic therapy to shorten treatment duration in critically-ill patients with bloodstream infections: a systematic review and meta-analysis.
    Robati Anaraki M; Nouri-Vaskeh M; Abdoli Oskouie S
    Infez Med; 2020 Mar; 28(1):37-46. PubMed ID: 32172259
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The use of procalcitonin for the management of sepsis in Internal Medicine wards: current evidence.
    Tosoni A; Paratore M; Piscitelli P; Addolorato G; De Cosmo S; Mirijello A;
    Panminerva Med; 2020 Mar; 62(1):54-62. PubMed ID: 31729202
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of procalcitonin to shorten antibiotic treatment duration in septic patients: a randomized trial.
    Nobre V; Harbarth S; Graf JD; Rohner P; Pugin J
    Am J Respir Crit Care Med; 2008 Mar; 177(5):498-505. PubMed ID: 18096708
    [TBL] [Abstract][Full Text] [Related]  

  • 39. One biomarker does not fit all: tailoring anti-infective therapy through utilization of procalcitonin and other specific biomarkers.
    Essmann L; Wirz Y; Gregoriano C; Schuetz P
    Expert Rev Mol Diagn; 2023; 23(9):739-752. PubMed ID: 37505928
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Procalcitonin-guided Antibiotic Treatment in Patients With Positive Blood Cultures: A Patient-level Meta-analysis of Randomized Trials.
    Meier MA; Branche A; Neeser OL; Wirz Y; Haubitz S; Bouadma L; Wolff M; Luyt CE; Chastre J; Tubach F; Christ-Crain M; Corti C; Jensen JS; Deliberato RO; Kristoffersen KB; Damas P; Nobre V; Oliveira CF; Shehabi Y; Stolz D; Tamm M; Mueller B; Schuetz P
    Clin Infect Dis; 2019 Jul; 69(3):388-396. PubMed ID: 30358811
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.